OTONOMY, INC.

SAN DIEGO, CA How do I update this listing?

Otonomy is based out of San Diego. Otonomy, Inc. operates as a clinical stage biopharmaceutical company. The Company develops therapeutics for treatment of inner and middle ear disorders.Whalewisdom has at least 103 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2011-06-02. The notice included securities offered of Equity

Create Alert

Contact Info

otonomy, inc.
4796 EXECUTIVE DRIVE
SAN DIEGO CA    92121

Business Phone: (619) 323-2200
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2011-06-02 D/A BIOTECHNOLOGY Equity 38,844,352 24,214,701 14,629,651
2010-09-03 D BIOTECHNOLOGY Equity 38,644,354 10,037,465 28,606,889
2010-06-09 D BIOTECHNOLOGY Equity 26,000,000 10,567,046 15,432,954
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
BRIAN DOVEY subscription required
    DIRECTOR
CARL LEBEL subscription required
    EXECUTIVE OFFICER
CARL LEBEL, PH.D. subscription required
    EXECUTIVE OFFICER
COURT TURNER subscription required
    DIRECTOR
DAVID WEBER subscription required
    EXECUTIVE OFFICER DIRECTOR
DOUGLAS DOWNS subscription required
    EXECUTIVE OFFICER
GERALD WROBLEWSKI subscription required
    EXECUTIVE OFFICER
HEATHER PRESTON subscription required
    DIRECTOR
JAY LICHTER subscription required
    DIRECTOR
JAY LICHTER, PH.D. subscription required
    EXECUTIVE OFFICER DIRECTOR
JEFFREY HARRIS subscription required
    DIRECTOR
JEFFREY HARRIS, M.D., PH.D. subscription required
    DIRECTOR
JOHN MCKEARN subscription required
    DIRECTOR
PAUL CAYER subscription required
    EXECUTIVE OFFICER
PETER BISGAARD subscription required
    DIRECTOR

Elevate your investments